Skip to main content
AngioLab, Inc. logo

AngioLab, Inc. — Investor Relations & Filings

Ticker · 251280 ISIN · KR7251280004 KO Professional, scientific and technical activities
Open in API
Filings indexed 173 across all filing types
Latest filing 2023-06-22 Regulatory Filings
Country KR South Korea
Listing KO 251280

About AngioLab, Inc.

https://angiolab.co.kr/

AngioLab, Inc. is a biotechnology company specializing in the discovery and development of angiogenesis inhibitors. The company develops pharmaceuticals and health functional foods to treat diseases associated with the abnormal growth of blood vessels. Its pipeline includes drug candidates targeting conditions such as age-related macular degeneration (AMD), with some candidates having undergone Phase II clinical trials. AngioLab has also developed Ob-X, a functional food ingredient based on its anti-angiogenic research platform.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최결과
Regulatory Filings Classification · 1% confidence The document is a short, structured announcement (under 1,000 characters) reporting the results of an Investor Relations (IR) event held on 2023-06-21. It provides details on the date, location, participants, and content of the session, and notes that the presentation materials are available on the Korea IR Council website. Since this is a notification of an event and the availability of materials rather than the presentation deck itself, it falls under the category of a regulatory filing announcement regarding corporate activities.
2023-06-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details changes in share ownership by major shareholders and special related parties, including reasons for changes such as director resignations and share acquisitions. This falls under the category of Major Shareholding Notification.
2023-04-04 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회 결과). It details the approval of financial statements, election of directors, and other resolutions passed during the meeting. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2023-03-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details specific changes to the company's board of directors, including the appointment of a new outside director and the resignation of an existing one. This falls directly under the category of Board/Management Information (MANG).
2023-03-30 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to specific employees and directors, including exercise prices, vesting periods, and valuation methods. This type of disclosure regarding capital structure changes and employee compensation via stock options falls under the category of share issuance or capital changes.
2023-03-30 Korean
사업보고서 (2022.12)
Annual Report Classification · 1% confidence The document is a 'Business Report' (사업보고서) for the 24th fiscal year (2022) of AngioLab, Inc. It contains comprehensive company information, financial data, management details, and business operations. This is the standard Korean regulatory filing equivalent to a 10-K in the US market, as it provides a full annual overview of the company's activities and financial performance. FY 2022
2023-03-22 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.